Rejection of drug a blow for Australians living with Alzheimer’s disease
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
A new treatment for people living with the early stages of Alzheimer’s disease or mild cognitive impairment has been rejected by the Therapeutic Goods Administration (TGA).
With Dementia becoming the leading cause of death in Australia, it’s disappointing news for those impacted by Alzheimers.
Guest: Dr Kaele Stokes is Dementia Australia’s Executive Director – Services, Advocacy & Research.
Presenter: Warren Andrew.
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
RECENT PODCAST
Associate Professor Micah Goldwater: Why Rational People Still Believe in Superstitions
Most of us consider ourselves rational, yet superstitions still shape everyday behaviour. Psychologist Micah Goldwater explains why scientific thinking and ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 11:19 — 15.5MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Associate Professor Lauren Rosewarne: Why Some Gen Z Men Are Returning to Traditional Gender Views
New research suggests some Gen Z men are expressing more traditional views about gender roles than older generations. Associate Professor ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 13:56 — 19.1MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Ben Cork: What the Pride in Sport Survey Reveals About Inclusion in Australian Sport
New results from the Pride in Sport Index survey reveal how LGBTQIA+ players, coaches and volunteers are experiencing sport across ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 13:17 — 18.2MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS